Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 February 2018 Photo Xolisa Mnukwa
Future of South Africa discussed at UFS peace conference
Delegates form the UFS and Osaka University gathered together at the Peace Conference.

The Department of Political Studies and Governance as well as the Centre for Africa Studies at the University of the Free State (UFS), together with the Osaka School of International Public Policy of Osaka University, jointly hosted a Quo Vadis South Africa Conference at the UFS on 12 and 13 February 2018.

Prof Hussein Solomon, Department of Political Studies and Governance, stated: “The focus is very much policy-oriented using academic insights to help resolve the myriad challenges confronting South Africa as a country as well as those on the continent.”

Prof Philippe Burger, Head of the Department of Economics and Acting Dean at the Faculty of Economic and Management Sciences at the UFS, spoke on the state of the national economy saying that factors contiguous to education could explain unemployment in South Africa. He pointed out that 60% of the population who were unemployed had not completed high school. He said only 20% of the employed population had tertiary education. Prof Burger said that labour-intensive, export-driven and investment-driven growth are the three integral sectors to consider when looking to improve the economy and overall growth of the country.

Prof Andre Duvenhage from North-West University delivered a presentation on his Strategic Perspectives of the ANC’s 2017 National Conference. Prof Duvenhage said that he had anticipated President Jacob Zuma’s recent departure from the ANC, saying his exit strategy had been negotiated behind the scenes. Some of his focal points included the state decay as a result of corrupt state practices, and the ideal future of the legitimate state which envisions the optimistic turn-around of the current condition of the South African Constitution.

“The future of Africa will be determined by politics”, said Jakkie Cilliers; Chairperson of the board, and Head of African futures and Innovation at the Institute for Security Studies. He explained that politics would drive events leading up to the national elective conference. This would offer political-election-outcome forecasts for 2019, 2024 and 2029 for the ANC, DA, EFF, and other national political parties. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept